CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase ; volume:103 ; number:11 ; day:21 ; month:9 ; year:2024 ; pages:4811-4815 ; date:11.2024
Annals of hematology ; 103, Heft 11 (21.9.2024), 4811-4815, 11.2024
- Urheber
-
Kramp, Laura-Jane
Heydrich-Karsten, Christiane
Sembill, Stephanie
Karow, Axel
Lion, Thomas
Chitadze, Guranda
Suttorp, Meinolf
Cario, Gunnar
Metzler, Markus
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-024-06011-4
- URN
-
urn:nbn:de:101:1-2501222116063.674016611764
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kramp, Laura-Jane
- Heydrich-Karsten, Christiane
- Sembill, Stephanie
- Karow, Axel
- Lion, Thomas
- Chitadze, Guranda
- Suttorp, Meinolf
- Cario, Gunnar
- Metzler, Markus
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia
Lymphoid specific gene rearrangement and mutation mechanisms in chronic myeloid leukemia blast crisis
Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis
Treatment of Relapsed Acute Myeloid Leukemia
Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia
Blast - T cell - interaction in pediatric acute myeloid leukemia
Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia
Lymphoid specific gene rearrangement and mutation mechanisms in chronic myeloid leukemia blast crisis
Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis
Treatment of Relapsed Acute Myeloid Leukemia
Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia
Blast - T cell - interaction in pediatric acute myeloid leukemia
Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia
Lymphoid specific gene rearrangement and mutation mechanisms in chronic myeloid leukemia blast crisis
Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis
Treatment of Relapsed Acute Myeloid Leukemia
Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia